Innovative, faster and more cost-effective technology identifies drug that inhibits SARS-CoV-2 growth in lab setting

Much progress has been made on the development of vaccines aiming at triggering human immunity to SARS-CoV-2, the virus that causes COVID-19. In addition, researchers at Baylor College of Medicine are involved in the development of antiviral drugs to treat infected individuals.

from Medical Xpress – latest medical and health news stories Source Link


Leave a Reply

Your email address will not be published. Required fields are marked *